| Jim Carroll | |
| Office: | Director of the Office of National Drug Control Policy |
| President: | Donald Trump |
| Term Start: | February 9, 2018 |
| Term End: | January 20, 2021 Acting: February 9, 2018 – January 3, 2019 |
| Predecessor: | Rich Baum (Acting) |
| Successor: | Regina LaBelle (Acting) |
| Office1: | White House Principal Deputy Chief of Staff |
| President1: | Donald Trump |
| Term Start1: | December 6, 2017 |
| Term End1: | February 9, 2018 |
| Predecessor1: | Kirstjen Nielsen |
| Successor1: | Zachary Fuentes |
| Party: | Republican |
| Education: | University of Virginia (BA) George Mason University (JD) |
James W. Carroll Jr. is an American attorney and government appointee, who served as director of the Office of National Drug Control Policy in the Trump Administration from February 9, 2018 until January 20, 2021.[1] [2]
Carroll received his B.A. from the University of Virginia and his J.D. degree from George Mason University.[3]
General Counsel in the Office of Management and Budget, and an attorney in the Office of the White House Counsel for Presidents Donald Trump and George W. Bush.[4] He later served as the White House Deputy Chief of Staff.[5] He was confirmed by the U.S. Senate as Office of National Drug Control Policy on January 2, 2019. Carroll was sworn into office by Vice President Mike Pence on January 31.[6]
In 2021, Carroll compared fentanyl to weapons of mass destruction.[7]